To recapitulate and test the effects of protein S on concizumab-mediated thrombin generation in hemophilia A, the flow-mediated model was modified by scaling kinetic rates to reflect thrombin generation in the presence or absence of protein S to examine its effects in hemophilia A with concizumab. This evidence concerns the gene PROS1 and hemophilia A.